Latest filing published 20 Jul 2023 for Sagimet Biosciences Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
KPCB PBD Associates, LLC: trading record in brief
KPCB PBD Associates, LLC discloses dealings in 2 companies, chiefly Trius Therapeutics Inc and Sagimet Biosciences Inc. The record holds 9 filings, for trades running from 6 August 2010 to 18 July 2023.
Purchases make up the whole of the open-market record (2 purchases, €3.1M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 20 July 2023 with a transaction in Sagimet Biosciences Inc. The last purchase on record was published on 10 August 2010, which is 5,935 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to KPCB PBD Associates, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 38,763 sharesSeries A Common StockSEC:0001104659-23-082737:1
- 1,860,712 sharesSeries A Common StockSEC:0001104659-23-082737:2
- 38,763 sharesCommon StockSEC:0001104659-23-082737:0
- 1,055,581 sharesCommon StockSEC:0001104659-10-043320:0
- 6,279 sharesCommon StockSEC:0001104659-10-043320:1
- 498,394 sharesCommon StockSEC:0001104659-10-043320:2
- 2,965 sharesCommon StockSEC:0001104659-10-043320:3
7 of 7 declarations
